Dexmedetomidine protects neurons from kainic acid-induced excitotoxicity by activating BDNF signaling
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 129, 104493
Abstract
No abstract availableKeywords
Funding Information
- Far Eastern Memorial Hospital (FEMH-2018-C-001)
This publication has 39 references indexed in Scilit:
- Ropivacaine Protects against Memory Impairment and Hippocampal Damage in a Rat Neurodegeneration ModelPharmacology, 2018
- Protective Effects of Bupivacaine against Kainic Acid-Induced Seizure and Neuronal Cell Death in the Rat HippocampusBiological and Pharmaceutical Bulletin, 2015
- Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidineEuropean Journal of Pharmacology, 2011
- The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicityBrain, Behavior, and Immunity, 2010
- Kainate, a double agent that generates seizures: two decades of progressTrends in Neurosciences, 2000
- Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)Neuropharmacology, 2000
- Chapter 24 Glutamate receptors in epilepsy1998
- Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization studyJournal of Neuroscience, 1994
- Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brainThe Lancet, 1993
- Ketamine, Phencyclidine, and MK‐801 Protect Against Kainic Acid‐Induced Seizure‐Related Brain DamageEpilepsia, 1990